Glioblastoma Therapy: Past, Present and Future
Glioblastoma (GB) stands out as the most prevalent and lethal form of brain cancer. Although great efforts have been made by clinicians and researchers, no significant improvement in survival has been achieved since the Stupp protocol became the standard of care (SOC) in 2005. Despite multimodality...
Main Authors: | Elena Obrador, Paz Moreno-Murciano, María Oriol-Caballo, Rafael López-Blanch, Begoña Pineda, Julia Lara Gutiérrez-Arroyo, Alba Loras, Luis G. Gonzalez-Bonet, Conrado Martinez-Cadenas, José M. Estrela, María Ángeles Marqués-Torrejón |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/25/5/2529 |
Similar Items
-
An Overview of Nanotherapeutic Drug Delivery Options for the Management of Glioblastoma
by: William H. Pentz, et al.
Published: (2023-08-01) -
Antiangiogenic Targets for Glioblastoma Therapy from a Pre-Clinical Approach, Using Nanoformulations
by: Gabriel Nery de Albuquerque Rego, et al.
Published: (2020-06-01) -
Neural Stem Cells as Potential Glioblastoma Cells of Origin
by: Alba Loras, et al.
Published: (2023-03-01) -
Externally Applied Electromagnetic Fields and Hyperthermia Irreversibly Damage Cancer Cells
by: Elena Obrador, et al.
Published: (2023-06-01) -
Ionizing radiation promotes primary ciliogenesis in glioblastoma cells
by: MA Wei, et al.
Published: (2021-04-01)